Journal of Biosafety and Biosecurity (Sep 2024)

Structure-based discovery of F. religiosa phytochemicals as potential inhibitors against Monkeypox (mpox) viral protein

  • Ranjan K. Mohapatra,
  • Ahmed Mahal,
  • Pranab K. Mohapatra,
  • Ashish K. Sarangi,
  • Snehasish Mishra,
  • Meshari A. Alsuwat,
  • Nada N. Alshehri,
  • Sozan M. Abdelkhalig,
  • Mohammed Garout,
  • Mohammed Aljeldah,
  • Ahmad A. Alshehri,
  • Ahmed Saif,
  • Mohammed Abdulrahman Alshahrani,
  • Ali S. Alqahtani,
  • Yahya A. Almutawif,
  • Hamza M.A. Eid,
  • Faisal M Albaqami,
  • Mohnad Abdalla,
  • Ali A. Rabaan

Journal volume & issue
Vol. 6, no. 3
pp. 157 – 169

Abstract

Read online

Outbreaks of Monkeypox (mpox) in over 100 non-endemic countries in 2022 represented a serious global health concern. Once a neglected disease, mpox has become a global public health issue. A42R profilin-like protein from mpox (PDB ID: 4QWO) represents a potential new lead for drug development and may interact with various synthetic and natural compounds. In this report, the interaction of A42R profilin-like protein with six phytochemicals found in the medicinal plant Ficus religiosa (abundant in India) was examined. Based on the predicted and compared protein–ligand binding energies, biological properties, IC50 values and toxicity, two compounds, kaempferol (C-1) and piperine (C-4), were selected. ADMET characteristics and quantitative structure–activity relationship (QSAR) of these two compounds were determined, and molecular dynamics (MD) simulations were performed. In silico examination of the kaempferol (C-1) and piperine (C-4) interactions with A42R profilin-like protein gave best-pose ligand-binding energies of –6.98 and –5.57 kcal/mol, respectively. The predicted IC50 of C-1 was 7.63 μM and 82 μM for C-4. Toxicity data indicated that kaempferol and piperine are non-mutagenic, and the QSAR data revealed that piperlongumine (5.92) and piperine (5.25) had higher log P values than the other compounds examined. MD simulations of A42R profilin-like protein in complex with C-1 and C-4 were performed to examine the stability of the ligand–protein interactions. As/C and C-4 showed the highest affinity and activities, they may be suitable lead candidates for developing mpox therapeutic drugs. This study should facilitate discovering and synthesizing innovative therapeutics to address other infectious diseases.

Keywords